Per O. Enger

Stavanger, 4011, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Phase 1 dose-escalation trial combining sulfasalazine and stereotactic radiosurgery in patients with recurrent glioblastoma.

Phase 1 dose-escalation trial combining sulfasalazine and stereotactic radiosurgery in patients with recurrent glioblastoma.

Journal: Redox biology
Published: May 13, 2026

Phase I trial combining sulfasalazine and gamma knife radiosurgery for recurrent glioblastoma.

Phase I trial combining sulfasalazine and gamma knife radiosurgery for recurrent glioblastoma.

Journal: MethodsX
Published: January 28, 2026

The Styryl Benzoic Acid Derivative DC10 Potentiates Radiotherapy by Targeting the xCT-Glutathione Axis.

The Styryl Benzoic Acid Derivative DC10 Potentiates Radiotherapy by Targeting the xCT-Glutathione Axis.

Journal: Frontiers in oncology
Published: October 01, 2021

Meclofenamate causes loss of cellular tethering and decoupling of functional networks in glioblastoma.

Meclofenamate causes loss of cellular tethering and decoupling of functional networks in glioblastoma.

Journal: Neuro-oncology
Published: April 17, 2021

A simple score to estimate the likelihood of pseudoprogression vs. recurrence following stereotactic radiosurgery for brain metastases: The Bergen Criteria.

A simple score to estimate the likelihood of pseudoprogression vs. recurrence following stereotactic radiosurgery for brain metastases: The Bergen Criteria.

Journal: Neuro-oncology advances
Published: July 10, 2020

Pretreatment of Glioblastoma with Bortezomib Potentiates Natural Killer Cell Cytotoxicity through TRAIL/DR5 Mediated Apoptosis and Prolongs Animal Survival.

Pretreatment of Glioblastoma with Bortezomib Potentiates Natural Killer Cell Cytotoxicity through TRAIL/DR5 Mediated Apoptosis and Prolongs Animal Survival.

Journal: Cancers
Published: May 23, 2019

Platelet-derived growth factor receptor α/glial fibrillary acidic protein expressing peritumoral astrocytes associate with shorter median overall survival in glioblastoma patients.

Platelet-derived growth factor receptor α/glial fibrillary acidic protein expressing peritumoral astrocytes associate with shorter median overall survival in glioblastoma patients.

Journal: Glia
Published: May 21, 2019

Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival.

Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival.

Journal: British journal of cancer
Published: April 26, 2019

Astrocytes enhance glioblastoma growth.

Astrocytes enhance glioblastoma growth.

Journal: Glia
Published: March 06, 2019

Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity.

Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity.

Journal: iScience
Published: April 27, 2018

Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.

Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.

Journal: Journal of neurosurgery
Published: August 19, 2017

Drug repurposing in cancer.

Drug repurposing in cancer.

Journal: Pharmacological research
Published: July 18, 2017
Showing 1-12 of 36

Last Updated: 09/26/2026